Gina Doody

Dr. Gina Doody

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 1995 in Science
Verified
Journal Article
Closed access
PDF file
GDGina Doody
Gina Doody
LJLouis B. Justement
Louis B. Justement
CDCatherine C. Delibrias
Catherine C. Delibrias
RMR. James Matthews
R. James Matthews
JLJiejian Lin
Jiejian Lin
DFDouglas T. Fearon
Douglas T. Fearon
CD22 is a membrane immunoglobulin (mIg)-associated protein of B cells. CD22 is tyrosine-phosphorylated when mIg is ligated. Tyrosine-phosphorylated CD22 binds and activates SHP, a protein tyrosine phosphatase known to negatively regulate signaling through mIg. Ligation of CD22 to prevent its coaggregation with mIg lowers the threshold at which mIg activates the B cell by a factor of 100. In secondary lymphoid organs, CD22 may be sequestered away from mIg through interactions with counterreceptors on T cells. Thus, CD22 is a molecular switch for SHP that may bias mIg signaling to anatomic sites rich in T cells.

2 March 1998 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KSKenneth G.C. Smith
Kenneth G.C. Smith
DTDavid M. Tarlinton
David M. Tarlinton
GDGina Doody
Gina Doody
MHMargaret L. Hibbs
Margaret L. Hibbs
DFDouglas T. Fearon
Douglas T. Fearon
Mice in which the Lyn, Cd22, or Shp-1 gene has been disrupted have hyperactive B cells and autoantibodies. We find that in the absence of Lyn, the ability of CD22 to become tyrosine phosphorylated after ligation of mIg, to recruit SHP-1, and to suppress mIg-induced elevation of intracellular [Ca2+] is lost. Therefore, Lyn is required for the SHP-1–mediated B cell suppressive function of CD22, accounting for similarities in the phenotypes of these mice.

1 June 2001 in Nature Immunology
Verified
Journal Article
Closed access
GDGina Doody
Gina Doody
SBSarah E. Bell
Sarah E. Bell
EVElena Vigorito
Elena Vigorito
ECElizabeth Clayton
Elizabeth Clayton
SMSimon McAdam
Simon McAdam
MTMartin Turner
Martin Turner

27 October 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GDGabriela Durcova-Hills
Gabriela Durcova-Hills
FTFuchou Tang
Fuchou Tang
GDGina Doody
Gina Doody
RTReuben Tooze
Reuben Tooze
MSM Azim Surani
M Azim Surani
Specification of primordial germ cells (PGCs) results in the conversion of pluripotent epiblast cells into monopotent germ cell lineage. Blimp1/Prmt5 complex plays a critical role in the specification and maintenance of the early germ cell lineage. However, PGCs can be induced to dedifferentiate back to a pluripotent state as embryonic germ (EG) cells when exposed to exogenous signaling molecules, FGF-2, LIF and SCF. Here we show that Trichostatin A (TSA), an inhibitor of histone deacetylases, is a highly potent agent that can replace FGF-2 to induce dedifferentiation of PGCs into EG cells. A key early event during dedifferentiation of PGCs in response to FGF-2 or TSA is the down-regulation of Blimp1, which reverses and apparently relieves the cell fate restriction imposed by it. Notably, the targets of Blimp1, which include c-Myc and Klf-4, which represent two of the key factors known to promote reprogramming of somatic cells to pluripotent state, are up-regulated. We also found early activation of the LIF/Stat-3 signaling pathway with the translocation of Stat-3 into the nucleus. By contrast, while Prmt5 is retained in EG cells, it translocates from the nucleus to the cytoplasm where it probably has an independent role in regulating pluripotency. We propose that dedifferentiation of PGCs into EG cells may provide significant mechanistic insights on early events associated with reprogramming of committed cells to a pluripotent state.

15 December 2012 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MCMario Cocco
Mario Cocco
SSSophie Stephenson
Sophie Stephenson
MCMatthew A Care
Matthew A Care
DNDarren Newton
Darren Newton
NBNicholas A Barnes
Nicholas A Barnes
RTReuben Tooze
Reuben Tooze
Plasma cells (PCs), the terminal effectors of humoral immunity, are short-lived unless supported by niche environments in which they may persist for years. No model system has linked B cell activation with niche function to allow the in vitro generation of long-lived PCs. Thus, the full trajectory of B cell terminal differentiation has yet to be investigated in vitro. In this article, we describe a robust model for the generation of polyclonal long-lived human PCs from peripheral blood B cells. After a proliferative plasmablast phase, PCs persist in the absence of cell division, with viability limited only by elective culture termination. Conservative predictions for PC life expectancy are 300 d, but with the potential for significantly longer life spans for some cells. These long-lived PCs are preferentially derived from memory B cells, and acquire a CD138high phenotype analogous to that of human bone marrow PCs. Analysis of gene expression across the system defines clusters of genes with related dynamics and linked functional characteristics. Importantly, genes in these differentiation clusters demonstrate a similar overall pattern of expression for in vitro and ex vivo PCs. In vitro PCs are fully reprogrammed to a secretory state and are adapted to their secretory load, maintaining IgG secretion of 120 pg/cell/day in the absence of XBP1 mRNA splicing. By establishing a set of conditions sufficient to allow the development and persistence of mature human PCs in vitro, to our knowledge, we provide the first platform with which to sequentially explore and manipulate each stage of human PC differentiation.

15 July 2015 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
FBFelipe A. Vieira Braga
Felipe A. Vieira Braga
KHKirsten M. L. Hertoghs
Kirsten M. L. Hertoghs
NKNatasja A. M. Kragten
Natasja A. M. Kragten
GDGina Doody
Gina Doody
NBNicholas A. Barnes
Nicholas A. Barnes
RLRené A. W. van Lier
René A. W. van Lier
Human cytomegalovirus (CMV) induces the formation of effector CD8+ T cells that are maintained for decades during the latent stage of infection. Effector CD8+ T cells appear quiescent, but maintain constitutive cytolytic capacity and can immediately produce inflammatory cytokines such as IFN‐γ after stimulation. It is unclear how effector CD8+ T cells can be constitutively maintained in a terminal stage of effector differentiation in the absence of overt viral replication. We have recently described the zinc finger protein Homolog of Blimp‐1 in T cells (Hobit) in murine NKT cells. Here, we show that human Hobit was uniformly expressed in effector‐type CD8+ T cells, but not in naive or in most memory CD8+ T cells. Human CMV‐specific but not influenza‐specific CD8+ T cells expressed high levels of Hobit. Consistent with the high homology between the DNA‐binding Zinc Finger domains of Hobit and Blimp‐1, Hobit displayed transcriptional activity at Blimp‐1 target sites. Expression of Hobit strongly correlated with T‐bet and IFN‐γ expression within the CD8+ T‐cell population. Furthermore, Hobit was both necessary and sufficient for the production of IFN‐γ. These data implicate Hobit as a novel transcriptional regulator in quiescent human effector‐type CD8+ T cells that regulates their immediate effector functions.